Literature DB >> 8219222

Variability of integrin alpha 2 beta 1 activity on human platelets.

T J Kunicki1, R Orchekowski, D Annis, Y Honda.   

Abstract

The activity and surface antigenicity of alpha 2 beta 1 on platelets from 27 normal subjects were found to vary significantly. A fourfold range of surface antigen correlates with a 20-fold variation in the ability of nonactivated, washed platelets to adhere to type I collagen and a fivefold variation in the adhesion of platelets to type III collagen. These differences in surface receptor are reflected in significant variation in the lag time required for type I collagen-induced platelet aggregation in platelet-rich plasma. Among the same individuals, no difference was observed in surface levels or activities of two other platelet integrins, the fibronectin receptor alpha 5 beta 1 and the fibrinogen receptor alpha IIb beta 3. In all cases studied, we observed complimentary differences in the incorporation of 125I into surface alpha 2 beta 1, in quantity of surface alpha 2 beta 1 antigens, and in alpha 2 beta 1 collagen receptor activity. Despite variations in these parameters, there was no difference in the electrophoretic mobility or isoelectric point of either integrin subunit among the individuals studied. The wide range of activity and antigenicity of this platelet collagen receptor may result from polymorphism(s) in the alpha 2 beta 1 genes, or the activity of alpha 2 beta 1 may be variably regulated by another gene product. The heterogeneity of platelet alpha 2 beta 1 that we describe in this report certainly explains previous discrepancies concerning the contributions of this integrin to platelet adhesion to collagens. Most importantly, differences in surface collagen receptor activity may correlate with a long-term risk toward thrombosis, impaired hemostasis, and/or cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8219222

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Role of platelet glycoprotein polymorphisms in cardiovascular diseases.

Authors:  Christian Meisel; José A López; Karl Stangl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-12       Impact factor: 3.000

2.  807C/T polymorphism in platelet glycoprotein Ia gene is not associated with retinal vein occlusion.

Authors:  Telma Gadelha; Ana Luiza Biancardi; Marilda Forster; Nelson Spector
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-06-28       Impact factor: 3.117

3.  Trans-dominant inhibition of integrin function.

Authors:  F Díaz-González; J Forsyth; B Steiner; M H Ginsberg
Journal:  Mol Biol Cell       Date:  1996-12       Impact factor: 4.138

4.  Packaging functionally important plasma proteins into the α-granules of human-induced pluripotent stem cell-derived megakaryocytes.

Authors:  Nanyan Zhang; Peter J Newman
Journal:  J Tissue Eng Regen Med       Date:  2019-01-04       Impact factor: 3.963

5.  The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.

Authors:  Norma E Ramirez; Zhonghua Zhang; Aasakiran Madamanchi; Kelli L Boyd; Lynda D O'Rear; Abudi Nashabi; Zhengzi Li; William D Dupont; Andries Zijlstra; Mary M Zutter
Journal:  J Clin Invest       Date:  2010-12-06       Impact factor: 14.808

Review 6.  Genetic dissection of platelet function in health and disease using systems biology.

Authors:  Wadie F Bahou
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-09       Impact factor: 3.722

7.  Small molecule inhibitors of integrin alpha2beta1.

Authors:  Sungwook Choi; Gaston Vilaire; Cezary Marcinkiewicz; Jeffrey D Winkler; Joel S Bennett; William F DeGrado
Journal:  J Med Chem       Date:  2007-10-04       Impact factor: 7.446

8.  Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity.

Authors:  L F Morton; P G Hargreaves; R W Farndale; R D Young; M J Barnes
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

Review 9.  Aspirin resistance and genetic polymorphisms.

Authors:  Josie A Cambria-Kiely; Pritesh J Gandhi
Journal:  J Thromb Thrombolysis       Date:  2002-08       Impact factor: 2.300

10.  The low-frequency isoform of platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding.

Authors:  Elisabetta Trifiro; Shirley A Williams; Yann Cheli; Kenichi Furihata; Fabio M Pulcinelli; Diane J Nugent; Thomas J Kunicki
Journal:  Blood       Date:  2009-05-22       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.